W World Corp.
OTC: WWHC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Eric W. Fangmann
- Employees
- 2
- Headquarters
- North Las Vegas, United States
- IPO year
- 1983
- Market cap
- $80.2M
- Website
- https://www.pharmoscorp.com
Loading WWHC…
Loading profile data…Frequently asked questions about WWHC
What does W World Corp. (WWHC) do?
W World Corp. is a biopharmaceutical firm dedicated to identifying and advancing innovative treatments for various metabolic and neurological conditions. Its research and development efforts specifically target ailments related to the brain-gut axis, pain and inflammation, autoimmune diseases, and gout. The company's pipeline features two primar...
Where does WWHC trade?
W World Corp. (WWHC) trades on the Other OTC.
What sector is WWHC in?
W World Corp. (WWHC) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of W World Corp.?
Eric W. Fangmann is the chief executive officer of W World Corp. (WWHC).
Where is W World Corp. headquartered?
W World Corp. is headquartered in United States.
Does WWHC pay a dividend?
W World Corp. (WWHC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did WWHC go public?
W World Corp. (WWHC) completed its initial public offering in 1983.